NKTR
NASDAQ · Pharmaceuticals
Nektar Therapeutics
$67.10
-1.26 (-1.84%)
Open$68.00
Previous Close$68.36
Day High$69.09
Day Low$66.98
52W High$109.00
52W Low$33.40
Volume—
Avg Volume926.7K
Market Cap2.33B
P/E Ratio—
EPS$-6.60
SectorPharmaceuticals
Analyst Ratings
Strong Buy
18 analysts
Price Target
-37.1% upside
Current
$67.10
$67.10
Target
$42.23
$42.23
$31.85
$42.23 avg
$63.47
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 109.53M | 129.89M | 246.52M |
| Net Income | -325,390,330 | -347,268,228 | 56.66M |
| Profit Margin | -297.1% | -282.2% | 23.0% |
| EBITDA | -275,809,241 | -310,706,485 | 106.98M |
| Free Cash Flow | — | — | 45.61M |
| Rev Growth | -15.7% | -15.7% | +15.2% |
| Debt/Equity | 0.70 | 0.70 | 0.88 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,164.89 | +1.04% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.47 | -0.19% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $149.50 | +1.79% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.74 | +0.29% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.62 | -0.70% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $71.33 | -0.10% | 11.5 | 30.15B |